COMMUNIQUÉS West-GlobeNewswire

TLC Announces Full Enrollment in Part 1 of Phase II Trial of TLC590 for Postsurgical Pain Management following Bunionectomy
08/04/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 08, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
PCI Biotech: Final confirmation of successful safety read-out in the Phase I Extension study
08/04/2019
Oslo (Norway), 8 April 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced final confirmation of [...]
CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
08/04/2019
Technical White Paper Also Available Via the Company’s Website LUND, Sweden, April 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’ [...]
GN Store Nord A/S issues options to the executive management and key employees
08/04/2019
In accordance with section 3.3.10 of the Nasdaq Copenhagen Rules for Issuers of Shares and with reference to the Remuneration Policy, including General Guidelines for Incentive Pay approved at the annual general meeting [...]
Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance
08/04/2019
Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance Paris – April 8, 2019 – Sanofi and Alnylam have agreed to conclude the research and option phase of the companies’ 2014 RNAi [...]
Genkyotex to Present Updated Interim Results From Phase 2 Trial of GKT831 in Primary Biliary Cholongitis at 2019 EASL International Liver Congress (ILC)
08/04/2019
Interim results selected for oral presentation and inclusion in “Best of ILC” summary All patients have completed treatment; favorable safety profile with no drop outs or treatment interruptions due to pruritus Final [...]
Genkyotex présente les résultats intermédiaires de son étude de phase 2 avec le GKT831 dans la cholangite biliaire primitive lors de l’International Liver Congress (EASL) 2019
08/04/2019
Résultats intermédiaires retenus pour présentation orale et sélectionnés parmi les meilleurs résumés « Best of ILC ». Tous les patients ont terminé le traitement ; profil de sécurité de GKT831 favorable, aucun abandon [...]
Quinton C. Oswald Explains His Biggest Business Growth Strategy
08/04/2019
Vero Beach, Florida, April 08, 2019 (GLOBE NEWSWIRE) -- After years of success in big Pharma and biotech field, Quinton C. Oswald recently took time to look back at his entire career and identify the main tip that [...]
Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders
08/04/2019
Consistent, Marked, and Sustained Lowering of Elevated Plasma Arginine with Pegzilarginase Clinically Impactful Responses Captured by Mobility and Adaptive Behavior Assessments Management to Host Conference Call at 8:30 [...]
RavenQuest Secures Health Canada Cultivation License at Edmonton Facility
05/04/2019
VANCOUVER, British Columbia, April 05, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally-licensed producer of cannabis, is pleased to [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/04/2019
BURLINGTON, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to five new employees consisting of an aggregate of 61,000 stock options and 26,900 [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/04/2019
WALTHAM Mass. and CRESTWOOD, Ky., April 05, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Codexis Senior Vice President of R&D Dr. Jim Lalonde Announces Plan to Resign
05/04/2019
REDWOOD CITY, Calif., April 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that Jim Lalonde, Ph.D., Senior Vice President of Research and Development, will [...]
ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market
05/04/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct [...]
Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference
05/04/2019
NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA™ Net Sales
05/04/2019
REDWOOD CITY, Calif., April 05, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that UDENYCA™ preliminary unaudited net sales for the quarter that ended March 31, 2019 are [...]
Visual Snow Initiative Presents Neuroscientist Ed Boyden with Váró Brain Sculpture for his Support to Advance a Cure
05/04/2019
CAMBRIDGE, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Paul Domb, co-founder, the Visual Snow Initiative (VSI) , presented an abstract brain sculpture to neuroscientist Dr. Edward (Ed) Boyden on April 3 at the McGovern [...]
Notice convening the Annual General Meeting of NeuroSearch A/S
05/04/2019
Company announcement 5 April 2019 Pursuant to Articles 8 and 9 of the Articles of Association, notice is hereby given of the Annual General Meeting to be held on Monday, 29 April 2019 at 10:00 am at Kromann Reumert, [...]
Signing of letter of intent with NTG and reason for proposals to the general meeting
05/04/2019
Company announcement 5 April 2019 Later today the Board of Directors will call the annual general meeting of NeuroSearch A/S ("NeuroSearch" or the “Company”). At the meeting, the Board of Directors will present a number [...]

Pages